Adcon T/NAlternative Names: Adcon-T/N; Adocon-T/N
Latest Information Update: 15 Oct 2009
$50 / €47 *
At a glance
- Originator Wright Medical Group
- Developer Wright Medical Group; Wright Medical Japan
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Post-surgical adhesions
Most Recent Events
- 15 Oct 2009 No development reported - Preregistration for Post-surgical adhesions in Japan (Topical)
- 14 Mar 2003 Gliatech's Adcon® Gel technology has been purchased by Wright Medical Group, Inc.
- 26 Sep 2002 Gliatech is auctioning its Adcon® assets